Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney Dunn

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Urology|March 7, 2002
Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black menAruna V Sarma, Craig A Jaffe, David Schottenfeld, et al.
Cancer|October 10, 2003
Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen-independent prostate carcinomaBeth Hellerstedt, Kenneth J Pienta, Bruce G Redman, et al.
Investigational New Drugs|August 6, 2010
Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignanciesBryan J Schneider, Gregory P Kalemkerian, Deborah Bradley, et al.
Journal of Sex & Marital Therapy|January 11, 2014
A pilot study of potential pre-operative barriers to couples' sexual recovery after radical prostatectomy for prostate cancerDaniela Wittmann, Laurel Northouse, Heather Crossley, et al.
BMC Medical Informatics and Decision Making|May 15, 2020
Prospective monitoring of imaging guideline adherence by physicians in a surgical collaborative: comparison of statistical process control methods for detecting outlying performanceMichael Inadomi, Karandeep Singh, Ji Qi, et al.
Cancer|August 28, 2009
Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): trial results and interleukin-6 analysis: a study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 ConsortiumDeborah Bradley, Dana Rathkopf, Rodney Dunn, et al.
Urology|November 7, 2015
Preparing Patients and Partners for Recovery From the Side Effects of Prostate Cancer Surgery: A Group ApproachKellie Paich, Rodney Dunn, Ted Skolarus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcomaRashmi Chugh, Rodney Dunn, Mark M Zalupski, et al.
The Prostate|September 22, 2005
Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancerZheng Fu, Yasuhide Kitagawa, Ronglai Shen, et al.
Female Pelvic Medicine & Reconstructive Surgery|June 27, 2017
Development and Validation of a Quantitative Measure of Adaptive Behaviors in Women With Pelvic Floor DisordersJohn T Wei, Rodney Dunn, Ingrid Nygaard, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Urology|March 7, 2002
Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black menAruna V Sarma, Craig A Jaffe, David Schottenfeld, et al.
Cancer|October 10, 2003
Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen-independent prostate carcinomaBeth Hellerstedt, Kenneth J Pienta, Bruce G Redman, et al.
Investigational New Drugs|August 6, 2010
Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignanciesBryan J Schneider, Gregory P Kalemkerian, Deborah Bradley, et al.
Journal of Sex & Marital Therapy|January 11, 2014
A pilot study of potential pre-operative barriers to couples' sexual recovery after radical prostatectomy for prostate cancerDaniela Wittmann, Laurel Northouse, Heather Crossley, et al.
BMC Medical Informatics and Decision Making|May 15, 2020
Prospective monitoring of imaging guideline adherence by physicians in a surgical collaborative: comparison of statistical process control methods for detecting outlying performanceMichael Inadomi, Karandeep Singh, Ji Qi, et al.
Cancer|August 28, 2009
Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): trial results and interleukin-6 analysis: a study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 ConsortiumDeborah Bradley, Dana Rathkopf, Rodney Dunn, et al.
Urology|November 7, 2015
Preparing Patients and Partners for Recovery From the Side Effects of Prostate Cancer Surgery: A Group ApproachKellie Paich, Rodney Dunn, Ted Skolarus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcomaRashmi Chugh, Rodney Dunn, Mark M Zalupski, et al.
The Prostate|September 22, 2005
Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancerZheng Fu, Yasuhide Kitagawa, Ronglai Shen, et al.
Female Pelvic Medicine & Reconstructive Surgery|June 27, 2017
Development and Validation of a Quantitative Measure of Adaptive Behaviors in Women With Pelvic Floor DisordersJohn T Wei, Rodney Dunn, Ingrid Nygaard, et al.
Pageof 3